Quality pays: IBSA production lines given stamp of approval by Russia30 April 2020
“Quality is one of the cornerstones on which all IBSA’s work is built. Product quality, but also production chain quality, which is subjected to very strict internal tests and in which our group constantly invests to maintain quality standards in line with the strictest global regulations”. This quote from Roberto Maglio, Sr Site Manager IBSA Group, summarises the IBSA philosophy applied to the production of all types of products. It is this philosophy that makes the company one of the biggest names in the sector, both in Italy and abroad.
The Ministry of Health of the Russian Federation has once again certified IBSA’s efforts, expressing “full satisfaction with IBSA Quality” as it confirmed export authorisation for injectable NSAID solutions. In March, the audit aimed at evaluating sterile solutions obtained by aseptic vial filling in the traditional vial and pre-filled syringe departments of the Lodi production site was concluded without observations.
The audit carefully examined all areas governed by Good Manufacturing Practices. The fully positive assessment relates in particular to the high technological standards adopted for plants and qualifications involving all production levels, including the strict process and product monitoring controls developed.
With this new certificate, IBSA is again confirmed as a reliable manufacturer of innovative, safe and effective pharmaceutical solutions.